prednisone has been researched along with Cognitive Decline in 4 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Zlotnik, Y | 1 |
Gadoth, A | 1 |
Abu-Salameh, I | 1 |
Horev, A | 1 |
Novoa, R | 1 |
Ifergane, G | 1 |
Shore, ND | 1 |
Saltzstein, D | 1 |
Sieber, P | 1 |
Mehlhaff, B | 1 |
Gervasi, L | 1 |
Phillips, J | 1 |
Wong, YN | 1 |
Pei, H | 1 |
McGowan, T | 1 |
Kararizou, E | 1 |
Anagnostou, E | 1 |
Kapaki, E | 1 |
Davaki, P | 1 |
Afshari, M | 1 |
Afshari, ZS | 1 |
Schuele, SU | 1 |
1 trial available for prednisone and Cognitive Decline
Article | Year |
---|---|
Results of a Real-world Study of Enzalutamide and Abiraterone Acetate With Prednisone Tolerability (REAAcT).
Topics: Abiraterone Acetate; Affect; Aged; Aged, 80 and over; Amnesia; Antineoplastic Combined Chemotherapy | 2019 |
3 other studies available for prednisone and Cognitive Decline
Article | Year |
---|---|
Case Report: Anti-LGI1 Encephalitis Following COVID-19 Vaccination.
Topics: Autoantibodies; Autoimmune Diseases; BNT162 Vaccine; Cognitive Dysfunction; COVID-19; Encephalitis; | 2021 |
Chronic inflammatory demyelinating polyneuropathy associated with neurosyphilis.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Biopsy; Cognitive Dysfunction; Electromyography; Ex | 2015 |
Pearls & oy-sters: Hashimoto encephalopathy.
Topics: Adrenal Cortex Hormones; Adult; Anticonvulsants; Autoantibodies; Brain Diseases; Cognitive Dysfuncti | 2012 |